Print Issue: January 01, 2013

EPO Use Down, IV Iron Use Up

Clinicians are prescribing less erythropoietin and more intravenous iron for anemic hemodialysis patients after the introduction of a prospective payment system (PPS) for dialysis services (“bundling”) and changes to ESA drug labels.

Next post in Kidney Week 2012 General News